Success Stories: NIW Petition Approved for Postdoctoral Fellow in Virginia in the Field of Cancer Biology

Client’s Testimonial:

“Thank you very much!! This is great news for me. Thank you for the hard work and extensive preparation for my case. I do not expect my case would be approved this fast. This proves evidence that your firm prepared the best petition letter for my case and also provides the best service to save my time. I will be more than happy to refer your firm to my friends who are going to file I-140.”

On April 11^th, 2016, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Cancer Biology (Approval Notice).

General Field: Cancer Biology

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: Taiwan

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Virginia

Approval Notice Date: April 11^th, 2016

Processing Time: 1 month, 25 days

Case Summary:

With a Ph.D. in Molecular and Cellular Biology and many years of experience working in the field of cancer biology, our client seemed to have suitable credentials to qualify for EB-2 NIW (National Interest Waiver). He was aware of our excellent approval rates and knew that the team at North America Immigration Law Group would do everything possible to build a strong case on his behalf. We evaluated his qualifications and determined that he was indeed a suitable candidate for this visa category. Here are some of the key points that we focused on when preparing our client’s EB-2 NIW petition:

When we filed the case, our client’s work had accumulated 159 citations—an impressive number that denoted the significance of his findings to other cancer biologists.
His extensive experience as a researcher resulted in the publication of 7 scientific papers at the time of filing.
Our client’s work focuses on a biological, chemical, and genetic investigation of cancer. His efforts are contributing to the United States’ research communities, including those of biochemical, biomedical, and clinical research, as well as the country’s healthcare systems.
Our client’s outstanding professional achievements have made him one of the top cancer biologists in the country. His work has drawn the attention of various researchers around the world, six of whom agreed to support his EB-2 NIW petition by signing recommendation letters. Here are several excerpts:

“[Client] is an excellent cancer biologist forging new headway in cancer research, specifically in the area of lung cancer, which afflicts over 2 million people in the U.S. annually. Given the prevalence and consequences of this disease, it is vital that we recruit and retain researchers of [Client’s] skill and ability.”

“Since researchers having such highly specialized skills are very difficult to replace, I strongly recommend his [Client’s] longer stay in the United States of America to continue reaping the many clinical benefits of his research in cancer biology, which has already greatly enhanced targeted treatments for cancer and congenital disease.”

“Ultimately, successes such as these are firm evidence that [Client] will continue to be an extraordinary cancer biologist, making original scientific contributions imperative to U.S. and worldwide interests.”

Attaining Petition Approval:

Because we were able to prove to the USCIS that our client’s work is important to the U.S. and that he is one of the most advanced individuals working in the field, the USCIS ultimately approved our client’s EB-2 NIW petition. We congratulate our client on this happy occasion and wish him well as he files an I-485 application (last step in green card proceedings).

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.